Guardion Health Sciences, Inc. Quarterly Operating Income (Loss) in USD from Q1 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Guardion Health Sciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2016 to Q2 2024.
  • Guardion Health Sciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.38M, a 2.75% increase year-over-year.
  • Guardion Health Sciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$4.39M, a 72.5% increase year-over-year.
  • Guardion Health Sciences, Inc. annual Operating Income (Loss) for 2023 was -$4.34M, a 75.1% increase from 2022.
  • Guardion Health Sciences, Inc. annual Operating Income (Loss) for 2022 was -$17.4M, a 29.6% increase from 2021.
  • Guardion Health Sciences, Inc. annual Operating Income (Loss) for 2021 was -$24.7M, a 189% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$4.39M -$1.38M +$39.1K +2.75% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$4.43M -$1.55M -$89.8K -6.13% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$4.34M -$679K +$10.7M +94% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$15M -$773K +$966K +55.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$16M -$1.42M +$291K +17% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$16.3M -$1.46M +$1.16M +44.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$17.4M -$11.3M +$3.17M +21.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$20.6M -$1.74M +$1.28M +42.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$21.9M -$1.71M +$2.83M +62.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$24.7M -$2.62M +$49.5K +1.85% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$24.7M -$14.5M -$11.2M -333% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 -$13.6M -$3.02M -$864K -40.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$12.7M -$4.54M -$3.83M -541% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$8.89M -$2.67M -$333K -14.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$8.55M -$3.36M +$735K +18% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$9.29M -$2.15M +$261K +10.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$9.55M -$708K +$2.1M +74.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$11.7M -$2.34M -$1.15M -97.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$10.5M -$4.09M -$2.74M -202% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-26
Q3 2019 -$7.76M -$2.41M -$1.27M -112% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$6.49M -$2.81M -$1.5M -114% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$4.99M -$1.18M +$1.15M +49.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$6.14M -$1.36M +$838K +38.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$6.98M -$1.14M +$441K +27.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$7.42M -$1.31M -$461K -54% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 -$6.96M -$2.33M -$1.68M -257% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$5.28M -$2.19M -$825K -60.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-14
Q3 2017 -$4.46M -$1.58M -$721K -83.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$3.74M -$854K +$139K +14% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$3.88M -$653K +$70.2K +9.72% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$3.95M -$1.37M Oct 1, 2016 Dec 31, 2016 10-K 2018-02-27
Q3 2016 -$861K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$993K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$723K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.